These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7835009)

  • 1. Clinical experience with etidronate in osteoporosis.
    Ryan PJ; Fogelman I
    Clin Rheumatol; 1994 Sep; 13(3):455-8. PubMed ID: 7835009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A; Snelder AA; Mulder H
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment.
    Montessori ML; Scheele WH; Netelenbos JC; Kerkhoff JF; Bakker K
    Osteoporos Int; 1997; 7(1):52-8. PubMed ID: 9102064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T; Campbell J; Bryant C; Lynch W
    Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures.
    Anderson FH; Francis RM; Bishop JC; Rawlings DJ
    Age Ageing; 1997 Sep; 26(5):359-65. PubMed ID: 9351480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
    Masud T; Mulcahy B; Thompson AV; Donnelly S; Keen RW; Doyle DV; Spector TD
    Ann Rheum Dis; 1998 Jun; 57(6):346-9. PubMed ID: 9771208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation.
    Orme SM; Simpson M; Stewart SP; Oldroyd B; Westmacott CF; Smith MA; Belchetz PE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):245-50. PubMed ID: 7923830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of early postmenopausal bone loss with cyclical etidronate.
    Adami S; Bruni V; Bianchini D; Becorpi A; Lombardi P; Campagnoli C; Ferrari A; Marchesoni T; Balena R
    J Endocrinol Invest; 2000 May; 23(5):310-6. PubMed ID: 10882149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cyclical etidronate on early postmenopausal bone loss: an open, randomized controlled study.
    Heath DA; Bullivant BG; Boiven C; Balena R
    J Clin Densitom; 2000; 3(1):27-33. PubMed ID: 10745299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
    Qureshi AM; Herd RJ; Blake GM; Fogelman I; Ralston SH
    Calcif Tissue Int; 2002 Mar; 70(3):158-63. PubMed ID: 11907712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
    Watts NB; Becker P
    Bone; 1999 Jan; 24(1):65-8. PubMed ID: 9916786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T; McGuigan L; Barbagallo S; Bryant C
    Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
    Crilly RG; Sebaldt RJ; Hodsman AB; Adachi JD; Brown JP; Goldsmith CH; Hanley DA; Olszynski WO; Ste-Marie LG; Stephenson GF
    Osteoporos Int; 2000; 11(7):607-14. PubMed ID: 11069195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ
    Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S; Matsu K; Uzawa M
    J Orthop Sci; 2003; 8(4):532-7. PubMed ID: 12898306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis.
    Ryan PJ; Blake GM; Herd R; Parker J; Fogelman I
    Calcif Tissue Int; 1993 Apr; 52(4):263-8. PubMed ID: 8467405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total-body DXA.
    Blake GM; Herd RJ; Fogelman I
    Osteoporos Int; 1996; 6(6):462-70. PubMed ID: 9116392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD; Watts NB; Licata AA; Harris ST; Genant HK; Wasnich RD; Ross PD; Jackson RD; Hoseyni MS; Schoenfeld SL; Valent DJ; Chesnut CH
    Am J Med; 1997 Dec; 103(6):468-76. PubMed ID: 9428829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.